About Clinica Ematologica - DiMI - Università degli Studi di Genova
"Dipartimento di Medicina Interna e Specialità Mediche dell'Università degli Studi di Genova. Ospita attività assistenziale in convenzione con l'Ospedale Policlinico San Martino ed è polo di Ricerca e Didattica, su cui è incardinato il corso di Studi in Medicina e Chirurgia."
Clinical Trials at Clinica Ematologica - DiMI - Università degli Studi di Genova
During the past decade, Clinica Ematologica - DiMI - Università degli Studi di Genova conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Ematologica - DiMI - Università degli Studi di Genova"
#1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Clinica Ematologica - DiMI - Università degli Studi di Genova
According to Clinical.Site data, the most researched conditions in "Clinica Ematologica - DiMI - Università degli Studi di Genova" are
"Rheumatoid Arthritis" (4 trials), "Acute Promyelocytic Leukemia" (2 trials), "Chronic Myeloid Leukemia" (2 trials), "Leukemia" (2 trials) and "Pregnancy" (2 trials). Many other conditions were trialed in "Clinica Ematologica - DiMI - Università degli Studi di Genova" in a lesser frequency.
Clinical Trials Intervention Types at Clinica Ematologica - DiMI - Università degli Studi di Genova
Most popular intervention types in "Clinica Ematologica - DiMI - Università degli Studi di Genova" are "Drug" (8 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Methotrexate" (4 trials), "Tocilizumab" (3 trials), "Corticosteroids" (1 trials), "DMARDs" (1 trials) and "Health Related Quality of Life (HRQOL) measures" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinica Ematologica - DiMI - Università degli Studi di Genova
The vast majority of trials in "Clinica Ematologica - DiMI - Università degli Studi di Genova" are
11 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Clinica Ematologica - DiMI - Università degli Studi di Genova
Currently, there are NaN active trials in "Clinica Ematologica - DiMI - Università degli Studi di Genova".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Clinica Ematologica - DiMI - Università degli Studi di Genova,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Clinica Ematologica - DiMI - Università degli Studi di Genova, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".